A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria by Murungi, L, Kamuyu, G, Lowe, B, Bejon, P, Theisen, M, Kinyanjui, S, Marsh, K, Osier, F

A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria. by Murungi, L, Kamuyu, G, Lowe, B, Bejon, P, Theisen, M, Kinyanjui, S, Marsh, K, Osier, F

Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria. by Osier, F, Murungi, L, Fegan, G, Tuju, J, Tetteh, K, Bull, P, Conway, D, Marsh, K

Dynamics and role of antibodies to Plasmodium falciparum merozoite antigens in children living in two settings with differing malaria transmission intensity. by Kangoye, D, Mensah, V, Murungi, L, Nkumama, I, Nebie, I, Marsh, K, Cisse, B, Bejon, P, Osier, F, Sirima, S

Plasmodium falciparum infection patterns since birth and risk of severe malaria: a nested case-control study in children on the coast of Kenya by Lundblom, K, Murungi, L, Nyaga, V, Olsson, D, Rono, J, Osier, F, Ogada, E, Montgomery, S, Scott, J, Marsh, K, Färnert, A

The ratio of monocytes to lymphocytes in peripheral blood correlates with increased susceptibility to clinical malaria in Kenyan children. by Warimwe, G, Murungi, L, Kamuyu, G, Nyangweso, G, Wambua, J, Naranbhai, V, Fletcher, H, Hill, A, Bejon, P, Osier, F, Marsh, K

Allelic diversity and naturally acquired allele-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 in Kenya. by Osier, F, Weedall, G, Verra, F, Murungi, L, Tetteh, K, Bull, P, Faber, B, Remarque, E, Thomas, A, Marsh, K, Conway, D

Severe Plasmodium falciparum malaria: targets and mechanisms associated with protection in Kenyan children. by Murungi, L, Sondén, K, Llewellyn, D, Rono, J, Guleid, F, Williams, A, Ogada, E, Thairu, A, Färnert, A, Marsh, K, Draper, S, Osier, F

Bi-isotype immunoglobulins enhance antibody-mediated neutrophil activity against Plasmodium falciparum parasites by Ogwang, R, Murugu, L, Nkumama, IN, Nyamako, L, Kai, O, Mwai, K, Murungi, L, Idro, R, Bejon, P, Tuju, J, Kinyanjui, SM, Osier, FHA

Cord blood IgG and the risk of severe Plasmodium falciparum malaria in the first year of life. by Murungi, L, Sondén, K, Odera, D, Oduor, L, Guleid, F, Nkumama, I, Otiende, M, Kangoye, D, Fegan, G, Färnert, A, Marsh, K, Osier, F

Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens. by Williams, A, Douglas, A, Miura, K, Illingworth, J, Choudhary, P, Murungi, L, Furze, J, Diouf, A, Miotto, O, Crosnier, C, Wright, G, Kwiatkowski, D, Fairhurst, R, Long, C, Draper, S

Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. by Osier, F, Fegan, G, Polley, S, Murungi, L, Verra, F, Tetteh, K, Lowe, B, Mwangi, T, Bull, P, Thomas, A, Cavanagh, DR, McBride, J, Lanar, D, Mackinnon, M, Conway, D, Marsh, K

Distinct kinetics of antibodies to 111 Plasmodium falciparum proteins identifies markers of recent malaria exposure by Yman, V, Tuju, J, White, MT, Kamuyu, G, Mwai, K, Kibinge, N, Asghar, M, Sundling, C, Sondén, K, Murungi, L, Kiboi, D, Kimathi, R, Chege, T, Chepsat, E, Kiyuka, P, Nyamako, L, Osier, FHA, Färnert, A

KILchip v1.0: a novel plasmodium falciparum merozoite protein microarray to facilitate malaria vaccine candidate prioritization by Kamuyu, G, Tuju, J, Kimathi, R, Mwai, K, Mburu, J, Kibinge, N, Kwan, M, Hawkings, S, Yaa, R, Chepsat, E, Njunge, J, Chege, T, Guleid, F, Rosenkranz, M, Kariuki, C, Frank, R, Kinyanjui, S, Murungi, L, Bejon, P, Farnert, A, Tetteh, K, Beeson, J, Conway, D, Marsh, K, Rayner, J, Osier, F